We are live on ! Find out more
CRVO icon

CervoMed

48 hedge funds and large institutions have $17.4M invested in CervoMed in 2025 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 12 increasing their positions, 15 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 6

7% more funds holding

Funds holding: 4548 (+3)

1% more capital invested

Capital invested by funds: $17.3M → $17.4M (+$160K)

0.77% more ownership

Funds ownership: 23.05%23.82% (+0.77%)

20% less repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 15

Holders
48
Holders Change
+3
Holders Change %
+6.67%
% of All Funds
0.58%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
9
Increased
12
Reduced
15
Closed
6
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
PS
51
Principal Securities
Iowa
-$13.5K -1,665 Closed
Royal Bank of Canada
52
Royal Bank of Canada
Ontario, Canada
-$13K -1,572 Closed
APW
53
Aventura Private Wealth
Florida
-$550 -68 Closed
Northwestern Mutual Wealth Management
54
Northwestern Mutual Wealth Management
Wisconsin
-$8 -1 Closed

CRVO Hedge Fund Activity: Q4 2025 in Review

48 of the 8,223 institutional investors tracked by Wall St. Rank reported a position in CervoMed (CRVO) for Q4 2025, worth a combined $17.4M — up 0.93% from $17.3M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new CRVO positions and 6 closed out — a net gain of 3 holders — while 12 added to existing stakes and 15 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $486K. The largest seller was AWM Investment Company, cutting an estimated $551K.

  • 48 institutional investors held CervoMed (CRVO) as of Q4 2025, up from 45 in Q3 2025.
  • Funds reported $17.4M of CervoMed stock for Q4 2025, up 0.93% quarter-over-quarter.
  • 9 funds opened new CervoMed positions in Q4 2025 and 6 closed out, a net change of +3 holders.
  • The largest CervoMed buyer in Q4 2025 was Morgan Stanley, an estimated $486K added.
  • The largest CervoMed seller in Q4 2025 was AWM Investment Company, an estimated $551K sold.

Based on aggregated 13F filings for Q4 2025.